The Story
First the first time ever, in Feb 2023, a patient in Lund, Sweden has received an embryonic stem cell transplant for their Parkinson’s disease. Doctors at Skåne University Hospital have transferred a stem cell-derived nerve cell to the patient which represents a breakthrough in the treatment of this disease.
Scientists generated the cells using embryonic stem cells with the hope they would serve as a replacement for the lost dopamine nerve cells.
According to Gesine Paul-Visse the potential effects of the STEM PD-product (STEM PD being the clinical trial run Sweden and the UK)might take some time, potentially years, to show but the patient has been discharged and evaluations will be carried out according to this studies protocol. The patient will be closely monitored to assess cell survival rate and any side effects of the treatment.
This individual is the first of eight individuals with Parkinson’s from Sweden and the UK who will receive this type of transplant. All the patients involved in this trial have been living with the disease for at least a decade and are considered to be at a moderate stage in the progression of the disease.